. 2004 Oct 30;54(6):587–598. doi: 10.1007/s00262-004-0602-0

Table 6.

Exceptionally long-term survivors among patients treated with ATV-NDV vaccine from autologous cell cultures

Tumor type	Median survival time expected (months)	Median survival observed^a
Ovarian carcinoma	~12	30 months DFS in 15/24 (63%)^b
Glioblastoma multiforme	~12	>36 months in 2/23 (9%)^c
Pancreatic carcinoma	~12	>36 months in 5/9 (55%)^d
Stomach carcinoma	~12	>36 months in 3/7 (43%)^e

^aNumber of long-term survivors per number of patients vaccinated is indicated for the respective time period

^bFrom [56]

^cFrom [6]

^dFrom [6]

^eFrom [6]